GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,074,000 | +0.1% | 257,582 | +1.6% | 2.62% | +20.9% |
| Q1 2022 | $11,060,000 | +8.8% | 253,543 | +9.2% | 2.17% | -5.2% |
| Q4 2021 | $10,165,000 | +7.7% | 232,227 | +0.9% | 2.29% | -7.1% |
| Q3 2021 | $9,436,000 | +12.5% | 230,229 | +9.3% | 2.46% | +20.6% |
| Q2 2021 | $8,385,000 | +14.2% | 210,570 | +3.4% | 2.04% | +8.4% |
| Q1 2021 | $7,341,000 | +1.1% | 203,649 | +4.6% | 1.88% | +7.0% |
| Q4 2020 | $7,264,000 | -0.9% | 194,638 | +0.7% | 1.76% | -5.1% |
| Q3 2020 | $7,329,000 | -99.9% | 193,320 | -0.4% | 1.86% | -16.4% |
| Q2 2020 | $7,964,716,000 | +96045.8% | 194,003 | -1.7% | 2.22% | -19.0% |
| Q1 2020 | $8,284,000 | -49.4% | 197,337 | -43.3% | 2.74% | -53.6% |
| Q4 2019 | $16,364,000 | – | 348,239 | – | 5.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |